Skip to main content

Main menu

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • Log out
  • My Cart

Search

  • Advanced search
Anticancer Research
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics
  • Register
  • Subscribe
  • My alerts
  • Log in
  • Log out
  • My Cart
Anticancer Research

Advanced Search

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Visit us on Facebook
  • Follow us on Linkedin
Research ArticleExperimental Studies

Loss of Tumour Suppressor p16 Expression in Initial Stages of Oral Oncogenesis

ELEFTHERIOS VAIRAKTARIS, CHRISTOS YAPIJAKIS, AMANDA PSYRRI, SOFIA SPYRIDONIDOU, ATHANASIOS YANNOPOULOS, ANDREAS LAZARIS, STAVROS VASSILIOU, ELEFTHERIOS FEREKIDIS, ANTONIS VYLLIOTIS, EMEKA NKENKE and EFSTRATIOS PATSOURIS
Anticancer Research March 2007, 27 (2) 979-984;
ELEFTHERIOS VAIRAKTARIS
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: lvairakt{at}med.uoa.gr
CHRISTOS YAPIJAKIS
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
AMANDA PSYRRI
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
SOFIA SPYRIDONIDOU
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
ATHANASIOS YANNOPOULOS
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
ANDREAS LAZARIS
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
STAVROS VASSILIOU
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
ELEFTHERIOS FEREKIDIS
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
ANTONIS VYLLIOTIS
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
EMEKA NKENKE
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
EFSTRATIOS PATSOURIS
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
  • PDF
Loading

Abstract

Background: The p16 tumour suppressor gene is known to be involved in regulation of the cell cycle. p16 expression in sequential histological stages of oral squamous cell carcinoma (OSCC) formation was investigated using an experimental model of induced oral carcinogenesis in Syrian golden hamsters. Materials and Methods: Thirty-seven animals were divided into one control group (N=7) and three experimental groups (N=10 each) which were treated with a carcinogen and sacrificed at 10, 14 and 19 weeks after treatment. Tumour sections were studied immunohistochemically using monoclonal antibodies against p16 protein. Results: p16 was found significantly increased in hyperplasia, sharply decreased in dysplasia and in the subsequent stages of oral carcinogenesis. Conclusion: Inactivation of p16 occurs at the early stage of oral mucosal dysplasia in the multistep process of oral tumourigenesis. Therefore, p16 may be considered as a useful prognostic marker for the progression of oral cancer.

  • p16
  • oral squamous cell carcinoma
  • immunohistochemistry
  • hamster

Footnotes

  • Received November 21, 2006.
  • Revision received January 16, 2007.
  • Accepted January 25, 2007.
  • Copyright© 2007 International Institute of Anticancer Research (Dr. John G. Delinassios), All rights reserved
PreviousNext
Back to top

In this issue

Anticancer Research
Vol. 27, Issue 2
March-April 2007
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
  • Front Matter (PDF)
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Anticancer Research.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Loss of Tumour Suppressor p16 Expression in Initial Stages of Oral Oncogenesis
(Your Name) has sent you a message from Anticancer Research
(Your Name) thought you would like to see the Anticancer Research web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
4 + 8 =
Solve this simple math problem and enter the result. E.g. for 1+3, enter 4.
Citation Tools
Loss of Tumour Suppressor p16 Expression in Initial Stages of Oral Oncogenesis
ELEFTHERIOS VAIRAKTARIS, CHRISTOS YAPIJAKIS, AMANDA PSYRRI, SOFIA SPYRIDONIDOU, ATHANASIOS YANNOPOULOS, ANDREAS LAZARIS, STAVROS VASSILIOU, ELEFTHERIOS FEREKIDIS, ANTONIS VYLLIOTIS, EMEKA NKENKE, EFSTRATIOS PATSOURIS
Anticancer Research Mar 2007, 27 (2) 979-984;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Reprints and Permissions
Share
Loss of Tumour Suppressor p16 Expression in Initial Stages of Oral Oncogenesis
ELEFTHERIOS VAIRAKTARIS, CHRISTOS YAPIJAKIS, AMANDA PSYRRI, SOFIA SPYRIDONIDOU, ATHANASIOS YANNOPOULOS, ANDREAS LAZARIS, STAVROS VASSILIOU, ELEFTHERIOS FEREKIDIS, ANTONIS VYLLIOTIS, EMEKA NKENKE, EFSTRATIOS PATSOURIS
Anticancer Research Mar 2007, 27 (2) 979-984;
Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
  • Info & Metrics
  • PDF

Related Articles

Cited By...

  • Oral Carcinogenesis Is not Achieved in Different Carcinogen-treated PAI-1 Transgenic and Wild-type Mouse Models
  • Expression Profiling of Cell Cycle Regulatory Proteins in Oropharyngeal Carcinomas Using Tissue Microarrays
  • Imbalance of Tumor Suppression Genes Expression Following Rat Tongue Carcinogenesis Induced by 4-Nitroquinoline 1-Oxide
  • Comparison of Cytology, Colposcopy, HPV Typing and Biomarker Analysis in Cervical Neoplasia
  • Google Scholar

More in this TOC Section

  • Low-dose Andrographolide Synergizes With Cytarabine or Vincristine in Plasma Cell Neoplasm Cell Lines
  • Enzalutamide Enhanced Honokiol-induced Apoptotic Insults to Drug-resistant Glioblastoma Cells via an Intrinsic Bak-mitochondrion-caspase Cascade Mechanism
  • Milk Extracellular Vesicle–mediated Delivery of siPRNP Suppresses Growth and Wound Closure in PC-3M Prostate Cancer Cells
Show more Experimental Studies
Anticancer Research

© 2026 Anticancer Research

Powered by HighWire